ライフサイエンスコーパス: Campylobacter infection

1 mmunological profile of the host response to Campylobacter infection.

2 wheeze, atopic sensitization) or symptomatic Campylobacter infection.

3 f culture-independent diagnostic methods for Campylobacter infection.

4 d from restaurants were additional risks for Campylobacter infection.

5 of the gastrointestinal tract as a result of Campylobacter infection.

6 defined as the likelihood of a diagnosis of Campylobacter infection.

7 of the incidence of GBS among patients with Campylobacter infection.

8 an do persons with ciprofloxacin-susceptible Campylobacter infection.

9 ed with the risk of developing GBS following campylobacter infection.

10 the strongest documented association is with Campylobacter infection.

11 illness costs are spent annually because of Campylobacter infection.

12 628-9575 US cases, 526-3830 are triggered by Campylobacter infection.

13 rvoir responsible for up to 80% of the human Campylobacter infections.

14 nducts surveillance for laboratory-confirmed Campylobacter infections.

15 out were the most important risk factors for Campylobacter infections.

16 cient to characterize mixed Helicobacter and Campylobacter infections.

17 } or any recreational water exposure [OR for Campylobacter infection, 2.7 {CI, 1.5-4.8}; OR for Esche

18 the 28 samples with Salmonella, Shigella, or Campylobacter infection, 93% had detectable fecal lactof

19 ential for understanding the epidemiology of Campylobacter infections, a major worldwide cause of bac

20 ntibiotic treatment may reduce the burden of Campylobacter infection and improve growth in children i

21 The association between Campylobacter infection and subsequent Guillain-Barre sy

22 dentify risk factors for sporadic intestinal Campylobacter infections and to determine the relative i

23 The first line of evidence supporting Campylobacter infection as a trigger of GBS is anecdotal

24 In 2012, a multistate outbreak of Campylobacter infections associated with unpasteurized m

25 scertain burden, and can distinguish between Campylobacter infections at the species level.

26 The negative predictive value for ruling out Campylobacter infection, defined as a posttest probabili

27 to develop best practice recommendations for Campylobacter infection diagnostic testing.

28 rade 3]; diarrhoea and fever associated with Campylobacter infection [grade 3]; recurrence of abdomin

29 Campylobacter infection has also been linked to the post

30 variation in the rates of culture-confirmed Campylobacter infection has been consistently observed a

31 estically acquired fluoroquinolone-resistant Campylobacter infection has been documented recently in

32 hemokines by dendritic cells (DCs) following Campylobacter infection has not yet been analyzed.

33 Persons with ciprofloxacin-resistant Campylobacter infection have a longer duration of diarrh

34 on and human health impact of Salmonella and Campylobacter infections have rarely been evaluated at t

35 Campylobacter infection in developing countries has not

36 ine candidate for preventing and controlling Campylobacter infection in humans and animal reservoirs.

37 Risk of Campylobacter infection in humans has been associated wi

38 , we describe the epidemiology and impact of Campylobacter infection in the first 2 years of life.

39 ones (e.g., ciprofloxacin) are used to treat Campylobacter infections in adults.

40 We describe the epidemiology of Campylobacter infections in the United States during 200

41 Campylobacter infection is a leading cause of ovine abor

42 Campylobacter infection is one of the major causes of ov

43 Campylobacter infection is the most commonly notified ba

44 e studies have speculated that Salmonella or Campylobacter infection may increase the risk of inflamm

45 We have developed experimental murine Campylobacter infection models which demonstrate efficie

46 The gastrointestinal manifestations of Campylobacter infection range from watery diarrhea to se

47 developing world and industrialized nations, Campylobacter infections remain a high priority for rese

48 One of every 1058 Campylobacter infections results in GBS, and 1 of 158 Ca

49 Further, Campylobacter infection stimulated the phosphorylation o

50 nt knowledge about the laboratory aspects of Campylobacter infection that may be pertinent to studies

51 oxacin, an antibiotic of choice for treating Campylobacter infection, through the pore of MOMP reveal

52 Campylobacter infection was also associated with increas

53 case-control study of persons with sporadic Campylobacter infection was conducted within 7 FoodNet s

54 Serological evidence of recent Campylobacter infection was detected in 81% of AMAN and

55 11 case patients with diarrhea and confirmed Campylobacter infection was enrolled, along with 1 age-

56 Among 290 persons with Campylobacter infection who did not take antidiarrheal m